VAS
BEAM icon

Vestmark Advisory Solutions’s Beam Therapeutics BEAM Stock Holding History

Vestmark Advisory Solutions’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.63M Sell
164,164
-12,701
-7% -$383K 0.05% 347
2026
Q1 		$4.21M Sell
176,865
-19,171
-10% -$532K 0.05% 388
2025
Q4 		$5.43M Buy
196,036
+29,739
+18% +$759K 0.07% 279
2025
Q3 		$4.04M Sell
166,297
-156,703
-49% -$3.12M 0.08% 255
2025
Q2 		$5.49M Buy
323,000
+168,479
+109% +$2.93M 0.08% 188
2025
Q1 		$3.02M Sell
154,521
-18,631
-11% -$488K 0.08% 275
2024
Q4 		$4.48M Buy
173,152
+39,250
+29% +$1M 0.15% 146
2024
Q3 		$3.28M Buy
133,902
+50,323
+60% +$1.3M 0.12% 178
2024
Q2 		$1.96M Sell
83,579
-31,207
-27% -$766K 0.08% 243
2024
Q1 		$3.79M Buy
114,786
+16,571
+17% +$516K 0.16% 149
2023
Q4 		$2.67M Buy
+98,215
New +$2.44M 0.14% 187

Other funds holding BEAM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Vestmark Advisory Solutions's BEAM Position: Q2 2026 in Review

Vestmark Advisory Solutions reduced its Beam Therapeutics (BEAM) stake by 7.2% in Q2 2026, selling an estimated $383K and leaving 164,164 shares worth $5.63M. The position accounts for 0.05% of the portfolio, ranked #347.

Vestmark Advisory Solutions first reported a position in BEAM in Q4 2023 and has held it in 11 quarters since. 277 funds tracked by Wall St. Rank hold BEAM as of Q2 2026.

  • Vestmark Advisory Solutions held 164,164 shares of Beam Therapeutics worth $5.63M as of Q2 2026.
  • Vestmark Advisory Solutions sold 12,701 Beam Therapeutics shares in Q2 2026, an estimated $383K.
  • Beam Therapeutics made up 0.05% of Vestmark Advisory Solutions's portfolio in Q2 2026, its #347 holding.
  • Vestmark Advisory Solutions first reported a position in Beam Therapeutics in Q4 2023 and has held it in 11 quarters since.
  • 277 funds tracked by Wall St. Rank held Beam Therapeutics as of Q2 2026.

Based on Vestmark Advisory Solutions's 13F filing for Q2 2026, filed 14 Aug 2026.